Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
The Centers for Disease Control and Prevention announced that it will expand its infectious disease surveillance programs at major airports around the country.
Astronaut Thomas Kenneth Mattingly, who helped bring the crew of Apollo 13 back to earth after an explosion threatened their lunar mission, has died at 87.
A new study published in the Journal of Personality and Social Psychology found that anger can actually be a constructive emotion that helps people achieve their goals.
A tarantula crossing the road in Death Valley National Park caused a traffic crash that sent a Canadian motorcyclist to the hospital, the National Park Service said.
